COVID-19

INTRODUCTION Pharmaceutical and life sciences companies are facing rapidly accelerating rates of disruption due to COVID-19, the new digital era, and traditional forces like new product ...

COVID-19 has introduced irreversible changes across the globe. As our world crawls into the new normal, the way we interact and transact may never be the same. People are increasingly ...

The COVID-19 pandemic has accelerated several changes in the pharmaceutical commercial model that were already underway: the digitization of sales rep-physician engagement, an influx of ...

The pandemic has brought forth several unexpected changes to companies’ business and commercial models across industries. For the life sciences industry, 2020 pushed organizations to ...

Overview of Current Market-Mix Methodologies For over 25 years, the pharmaceutical industry has relied on marketing-mix (MMx) analyses to measure the effectiveness of their promotional ...

This blog is based on the guest post, "How has COVID-19 Accelerated the Need for Effective Physician Outreach?” featured in the December 2020 edition of BW Wellbeingworld. Click here to ...

States Feeling Budget Pressures Due to Expanding Medicaid Enrollment Economic recession effects induced by state and local public policy responses to the COVID-19 pandemic (according to the ...

What Should the Pharma Industry Learn from the 2020 Elections? 1.1 Current State of Party Control of the White House and Congress The November 2020 elections for President, Senate, and ...

Axtria Blogs have continued to follow the uncertain course of the US economic recovery, like an “accordion” or repeating “W-shape” induced by the COVID-19 pandemic [1-2]. Newly released ...